Description
Fusion protein immunotherapies such as the bispecific T cell engager (BiTE) have displayed promising potential as cancer treatments capable of engaging the immune system against tumor cells.
Copyright Statement
Download count: 0
Details
Contributors
- Schaefer, Braeden Scott (Author)
- Mor, Tsafrir (Thesis director)
- Mason, Hugh (Committee member)
- Cook, Rebecca (Committee member)
- School of Life Sciences (Contributor, Contributor)
- Barrett, The Honors College (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2019-05
Subjects
Resource Type
Collections this item is in